Kjartan F. Herrik
Valby, 2500, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pharmacological modulation of wakefulness and extracellular hypothalamic histamine release in adult male mice using TAK-925, modafinil, pitolisant, MK-8133 and Lu AF11167.
Journal: Neuropharmacology
Published: October 15, 2025
Sub-anesthetic doses of ketamine increase single cell entrainment in the rat auditory cortex during auditory steady-state response.
Journal: Journal of psychopharmacology (Oxford, England)
Published: May 11, 2023
Gating small conductance calcium-activated potassium channels in the thalamic reticular nucleus.
Journal: Synapse (New York, N.Y.)
Published: April 14, 2023
The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans.
Journal: Psychopharmacology
Published: February 23, 2022
Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat.
Journal: Frontiers in psychiatry
Published: July 06, 2021
Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
Journal: Neuropharmacology
Published: June 07, 2019
Pharmaco-electroencephalographic responses in the rat differ between active and inactive locomotor states.
Journal: The European journal of neuroscience
Published: June 18, 2018
The 5-HT3 receptor antagonist ondansetron potentiates the effects of the acetylcholinesterase inhibitor donepezil on neuronal network oscillations in the rat dorsal hippocampus.
Journal: Neuropharmacology
Published: June 08, 2018
The 5-HT6 receptor antagonist idalopirdine potentiates the effects of donepezil on gamma oscillations in the frontal cortex of anesthetized and awake rats without affecting sleep-wake architecture.
Journal: Neuropharmacology
Published: April 28, 2016
The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus.
Journal: Neuropharmacology
Published: November 13, 2015
CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate.
Journal: Frontiers in pharmacology
Published: December 20, 2011
Last Updated: 09/26/2026